Hox genes encode essential transcription factors that control patterning during embryonic development. Distinct combinations of nested Hox expression domains establish cell and tissue identities 1-3 . Consequently, spatial or temporal de-regulation of Hox genes can cause severe alterations of the body plan 3 . While HOX factors have very similar DNA binding motifs, their binding specificity is, in part, mediated by co-factors 4-6 . Yet, the interplay between HOX binding specificities and the cellular context remains largely elusive. To gain insight into this question, we took advantage of developing limbs for which the differential expression of Hox genes is well-characterized 7 . We show that the transcription factors HOXA13 and HOXD13 (hereafter referred as HOX13) allow another HOX factor, HOXA11, to bind loci initially assumed to be HOX13-specific. Importantly, HOXA11 is unable to bind these loci in distal limbs lacking HOX13 function indicating that HOX13 modulates HOXA11 target repertoire.
The Hox family of developmental genes encoding transcription factors (TFs) have pivotal roles in organogenesis and patterning. Their differential expression along the main body axis establishes positional information that instructs cells about their fate, ultimately generating morphological diversity [1] [2] [3] . The wide-range of HOX-dependent genetic programs is intriguing considering that the various HOX TFs have similar DNA-binding properties 6 . Several studies uncovered the relevance of co-factors, notably the PBX/Exd family of TFs, in increasing DNAbinding specificity [4] [5] [6] . Analyses using micromass culture from primary mesenchymal limb bud cells revealed that group 11 and 13 Hox genes cluster in the same subgroup 10 despite the fact that HOXA11/HOXD11 are required for the zeugopod (forearm) developmental program 11 while HOXA13 and HOXD13 are mandatory for digit development 12 (Fig. 1a) . This raises the question of the extent to which HOX TF specificity may be modulated spatially/temporally during embryogenesis.
To address this question, we investigated the impact of the cellular context on the target repertoire of HOXA11 and HOX13, which are normally expressed in mutually exclusive domains in the developing limb but have highly similar homeodomain sequences (e.g. ref. 10 ; Fig. 1b ). We first analyzed the genome-wide binding of HOXA11 in wild type limb buds, at embryonic day 11.5 (E11.5), by performing Chromatin immunoprecipitation followed by high throughput sequencing (ChIP-seq) and compared the data with those previously reported for HOX13 (ref.13) ( Fig. 1 ;
Extended Data Fig.1 ). Reminiscent of the distribution of HOX13-bound loci in distal limbs 13 , the vast majority of HOXA11 ChIP-seq peaks are located at genomic regions distinct from transcriptional start site (TSS; Fig. 1c ). While most peaks are common in both data sets, 23% of HOXA11 (i.e 2128) or HOXA13 (i.e 2130) targets are located at distinct loci ( Fig. 1d ) and de novo motif search uncovered slight differences in HOX motifs for common versus specific targets ( Fig.   1e ). We next tested whether the cellular environment could modulate the specificity distinguishing HOXA11 from HOXA13 binding sites. To this aim, we analyzed HOXA11 binding profile in Prrx1:Cre;Rosa26 Hoxa11/Hoxa11 limb buds in which HOXA11 is ectopically expressed distally 14 (R26 A11d/A11d in Fig. 2a ). Compared to the wild type binding profile, we observed ectopic binding of HOXA11 in R26 A11d/A11d limb buds ( Fig. 2b-c) . Interestingly, distally expressed HOXA11 binds to loci, which, in wild type limbs, are specific to HOX13 and are enriched for the DNA motif associated with HOX13 specific sites ( Fig. 2d, Extended Data Fig. 3a-c) . To further assess whether these changes in HOXA11 binding are due to the presence of HOX13 or triggered by other factors specific to distal limb cells, we took advantage of the Hox13-/-mutant 12 in which Hoxa11 becomes distally expressed 13, 15, 16 . Analysis of HOXA11 genome-wide binding in Hox13-/-limbs revealed that all the ectopic HOXA11 binding sites observed in R26 A11d/A11d limbs were absent in Hox13-/-limbs ( Fig. 2d ), indicating that the ectopic binding of HOXA11 occurring in distal limbs requires HOX13 function. Together these results suggest that the binding specificity of HOXA11 and HOXA13 does not simply rely on distinct DNA motifs. Rather, our finding supports the idea that the primary driver for the distinct HOXA11 and HOXA13 binding profiles in wild type limb buds is related to their discrete expression domain, differentially expressed co-factors and possibly to chromatin accessibility.
To assess whether chromatin accessibility may influence HOXA11 and HOXA13 binding, we performed ATAC-seq (Assay for Transposase Accessible Chromatin followed by highthroughput sequencing 17 ) on proximal and distal wild type limb buds. We identified 1629 sites showing stronger accessibility in distal limb buds ( Fig. 3a , Extended Data Fig. 4a ). These sites tend to be associated with genes involved in digit morphogenesis (Extended Data Fig. 4c -g) and are enriched for the previously identified HOX13 motif ( Fig. 3b ). Accordingly, HOX13 binds these distally accessible sites but not the proximal-specific accessible sites ( Fig. 3c ). Previous analysis of HOX13-dependent gene regulation revealed that the transition from the early to the distal/late limb developmental program relies on HOX13 function and it was proposed that such switch in developmental program could be associated with a potential pioneer activity of the HOX13 TFs 13 .
The finding that cellular environment modulates HOXA11 binding in a HOX13-dependent manner ( Fig. 2 ) thus prompted us to test whether the ectopic HOXA11 binding at loci normally specifically bound by HOX13 could originate from changes in chromatin accessibility mediated by HOX13 TFs.
We thus performed ATAC-seq on wild type and Hox13-/-distal limbs ( Fig. 3d , Extended Data Fig.   5a ). We identified substantial changes in chromatin accessibility (Fig. 3e ), and interestingly, loci with decreased accessibility were enriched for HOX13 binding in the wild type distal limb (Extended Data Fig. 5b ). In contrast, loci with increased accessibility in Hox13-/-distal limbs did not overlap with HOX13 ChIP-seq peaks identified in the wild type context, suggesting that this gain in chromatin accessibility is an indirect outcome of Hox13 inactivation (Extended Data Fig. 5b ). We then analyzed the relationship between HOXA11 and HOX13, at sites loosing accessibility in Hox13-/-distal limbs. While HOXA11 and HOXA13 binding are correlated (R 2 =0.57) at sites with unchanged accessibility, HOX13-dependent accessibility shows an unambiguous preference for HOXA13-bound loci and a low correlation with HOXA11 (R 2 =0.18) (Extended Data Fig. 5e ).
Importantly, we found that expression of HOXA11 in distal limb cells leads to its ectopic binding at loci whose chromatin accessibility relies on HOX13 ( Fig. 3f ). Together these results suggest that HOX13-dependent chromatin accessibility allows HOXA11 binding at loci that are HOX13-specific in wild type limb, i.e. in a context where Hox13 and Hoxa11 are expressed in mutually exclusive domains.
Among the genomic regions where HOX13-dependent chromatin accessibility allows for HOXA11 binding, we found several previously characterized enhancers. For instance, several enhancers controlling HoxD gene expression in distal limb [18] [19] [20] were identified as loci with ectopic HOXA11 binding (Fig. 3g ). The HOX13-dependent chromatin accessibility is also consistent with the loss of transcriptional activity previously reported at these enhancers in Hox13-/-limbs 13, 21 .
Similarly, HOXA11 binding dependent on HOX13 is observed at the enhancer driving Hoxa11 antisense transcription ( Fig. 3h ), whose function ultimately prevents distal expression of Hoxa11 14 .
We next tested whether HOX13-dependent chromatin accessibility could be modulated by cell identity. To this aim, we performed single-cell ATAC-seq using wild type and Hox13-/-E11.5 forelimb buds (Extended Fig. 6 ). Cell clustering was based on the similarity of their genome-wide chromatin accessibility and the resulting clusters ( Fig. 4a ) were annotated using aggregated accessibility profiles of several marker genes (Extended Fig. 7 ). Consistent with Hox13 being expressed in the limb mesenchyme, we found that clusters present in wild type and absent in Hox13-/-limbs (and vice-versa) are restricted to mesenchymal cells ( Fig. 4b-c ). More specifically, cluster 2 is completely lost upon Hox13 inactivation and cluster 6 and 7 are drastically reduced ( Fig. 4b ),
confirming the loss of chromatin accessibility uncovered from the bulk ATAC-seq analysis. In addition, occurrence of a Hox13-/-specific cluster (cluster 3, Fig. 4c ) suggested that chromatin accessibility did not switch to a proximal limb profile but may correspond to an interrupted transition of progenitor cells towards specified distal limb cells. Analysis of the aggregated cluster ATAC-seq signal confirmed cell type specific loss of chromatin accessibility at HOX13 target sites. While our scATAC-seq data was consistent with the results obtained from bulk ATAC-seq assay, it also revealed additional loci dependent on HOX13 for their accessibility. For instance, the enhancer driving Bmp2 expression in distal limb 22 only showed reduced accessibility in bulk ATAC-seq (Extended Data Fig. 5g ) while the scATAC-seq revealed an unambiguous loss specifically in clusters corresponding to distal mesenchyme ( Fig. 4d , first column). Our data also suggested that the region previously identified as the bmp2 distal limb enhancer likely encompasses two adjacent enhancers, with only one showing HOX13 dependency for its accessibility. Consistent with our results, Bmp2 expression in Hox13-/-limbs is lost distally while unaffected in the proximal limb where Hox13 is normally not expressed ( Fig. 4e ). Similarly, loss of chromatin accessibility in Hox13-/-limbs were observed at putative enhancers located in the neighborhood of genes expressed in distal limb buds ( Fig. 4d ) as well as at the previously identified enhancer driving Hoxa11 antisense transcription distally ( Fig. 4d , right column). Of note, 'non-mesenchyme' clusters were unaffected by Hox13 inactivation (Fig. 4a ), consistent with Hox13 not being expressed in these cells.
Together, these data provide evidence that HOX13 has the capacity of triggering the switch from a 'closed' chromatin conformation to an accessible one and allows the binding of other TFs.
Whether this functional characteristic is specific to HOX13 or a common feature of the HOX family of TFs remains to be investigated but we propose that pioneer activity of HOX TFs is likely key to HOX-dependent cell fate and patterning events. Importantly, the evidence that HOX13 modifies the HOXA11 genome-wide binding repertoire reveals a mechanism that contributes to defining the tissue-specific spectrum of HOX targets. This mechanism does not belittle the importance of HOX cofactors as de novo motif analysis at loci with HOX13-dependent chromatin accessibility did not reveal an obvious motif distinguishing these loci from other HOX13 targets ( Fig. 1e ). Yet, the fact that a subset of HOX13 targets remain in an accessible chromatin state in Hox13-/-limb does not exclude the possibility that these targets could be switched to an accessible state by HOX13 in other cellular/tissue environments. Interestingly, a recent study investigating the in vivo HOX binding specificity at the vvl1+2 enhancer in Drosophila melanogaster suggests that HOX binding specificity relies on a combination of three parameters: binding specificity influenced by HOX cofactor(s), HOX monomers and interaction with collaborator proteins 23 . Our work reveals that the HOX13 pioneer activity, and possibly that of the other HOX factors, is one of the key parameters that specifies the HOX target repertoires.
The impact of the HOX13 TFs on chromatin accessibility at HoxD enhancers raises the possibility that it contributes to the dynamic expansion of the HoxD expression domain during the progression of distal limb bud development. Interestingly, it was previously proposed that the increase/expansion of the Hoxd13 expression domain might have been a driver for the origin of the novel endoskeletal elements characterizing the fin-to-limb transition 24 . In this view, the HOX13dependent chromatin accessibility identified here for a subset of the HoxD enhancers might have contributed to the molecular evolution that allowed the emergence of digits. In addition, the HOX13dependent chromatin accessibility at the enhancer driving antisense transcription at the Hoxa11 locus, which is required to prevent distal Hoxa11 expression and polydactyly 14, 25 , supports a possible role of HOX13 pioneer activity in the molecular network that underlies the evolution of the pentadactyl state characterizing most modern tetrapods. Consistent with this view, we found that the enhancer driving Hoxa11 antisense transcription is in an accessible state in the presumptive digit domain of chicken limb buds while it is in a 'closed' configuration in early limb buds, when Hox13 genes are not expressed (Extended data Fig.9 ). This result corroborates the findings in wild type and mutant mouse limb buds and points to a conserved role of the HOX13 TFs in regulating chromatin accessibility during both mouse and chicken embryonic development. Based on these data, we propose that HOX13 pioneer activity could have been a key feature contributing to the emergence of digits and subsequent refinement of digit number in modern tetrapods.
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METHODS (ONLINE-ONLY)

Mouse lines
Hoxa13null (Hoxa13 Str ), Hoxd13null (Hoxd13 lacZ ), Rosa Hoxa11 mouse lines were previously described 12, 14, 26 . All mice were maintained in mixed background (C57BL/6 X 129). Noon of the day of the vaginal plug was considered as E0.5. Mice and embryos were genotyped by PCR using genomic DNA extracted from tail biopsy specimens and yolk sacs, respectively. Mice work at the Institut de Recherches Cliniques de Montréal (IRCM) was reviewed and approved by the IRCM animal care committee (protocols 2015-14 and 2017-10).
Chromatin Immunoprecipitation and Sequencing
HOXA11 ChIP was performed in forelimb buds of CD1 (wild type) and Prx1Cre; Rosa Hoxa11/Hoxa11 (R26 A11d/A11d ) mice at E11.5 in the same conditions as previously described for HOX13 ChIP 13 .
Chromatin was cross-linked using a combination of disuccinimidyl glutarate (DSG) and 
ATAC-seq
Dissection of proximal and distal of forelimb buds from wild type embryos and distal forelimb buds of Hox13 -/embryos 13 were performed at E11.5. All samples for ATAC-seq were processed as previously described 27 
Single cell ATAC-seq
Dissection of forelimb buds from wild type embryos and Hox13-/-embryos 13 After centrifugation at 300 rcf for 5 minutes at 4°C, the pellet of nuclei was re-suspended in diluted nuclei buffer in order to have 3500 nuclei/µl and processed using Chromium Single Cell ATAC Reagent Kits (10x Genomics, Pleasanton, CA) following the manufacturer recommendation. Briefly, nuclei were incubated in a Transposition Mix that includes a Transposase that preferentially fragments the DNA in open regions of the chromatin and simultaneously, adapter sequences were added to the ends of the DNA fragments. GEMs were then generated, using partitioning oil, in order to contain a single nucleus and a Master Mix to produce 10x barcoded single-stranded DNA after thermal cycling. The Chromium Single Cell ATAC Library was amplified and double sided size selected. Samples were controlled at multiple steps during the procedure by running on BioAnalyzer.
Libraries were sequenced on Hiseq 4000 with 100 bp paired-end reads.
RNA Preparation and Sequencing
Dissection of proximal and distal of forelimb buds were performed at E11.5 as described above. The dissected limb buds were stored at -80 in Qiagen RNAlater until genotyping was performed. RNA was extracted from two independent embryos and performed in biological duplicate using RNAeasy Plus mini kit (Qiagen 74134). mRNA enrichment, library preparation and flow-cell preparation for sequencing were performed by the IRCM Molecular Biology Core Facility according to Illumina's recommendations. Sequencing was done on a HiSeq 2500 instrument with a paired-end 50 cycles protocol.
ChIP-seq and ATAC-seq Data analysis
ChIP-seq and ATAC-seq reads were aligned to the mm10 genome using bowtie v. Hox13 peaks, HOXA/D13 peaks underwent the same stringent filter. To obtain a high confidence list of specific peaks we considered binding as a specific peak when it did not overlap any peak with a pvalue of 10 -5 from either replicate of the compared ChIP. This strategy likely eliminate weakly specific or enriched binding (false negative) but allowed to focus on highly pure lists (true positive) of common versus specific peaks.
Heatmaps and average profiles were generated using the Easeq software 31 . ChIP-seq and ATAC-seq data were visualized on the IGV software 32 using BigWig files generated using the makeUCSCfile HOMER command. For ATAC-seq differential analysis, peaks from ATAC datasets (proximal wild type and distal wild type for the proximo-distal comparison; distal wild type and distal Hox13-/-for the WT vs Hox13-/-comparison) were merged using HOMER v4.9.1 mergePeaks tool to obtain a file with all the unique position from all the ATAC-seq datasets. ATAC-seq signals were quantified in these different datasets using the analyzeRepeats.pl HOMER command and differential accessibility analyses were performed using getDiffExpression.pl with default parameters, which uses Deseq2 (ref 33 ) to perform differential enrichment analysis. Peaks showing differential accessibility of more than two folds and an adjusted pvalue smaller than 0.05 were considered differentially accessible.
Motif Analysis
Motif analysis on ChIP data was performed using a fixed 200bp window around the peak center.
Motif analysis on ATAC-seq data was performed on the whole peak window as the aim is to identify any factors associated with chromatin accessibility and these may not be at the center of the ATACseq peak. In all cases, HOMER findMotifsGenome command was used to perform de novo analysis against background sequences generated by HOMER that matches GC content. When the motif rank is not shown, only the top scoring motif based on its p-value is shown.
RNA-seq Data Analysis
Strand specific paired-end reads were aligned to the mm10 reference genome using TopHat2 (ref 34 ) with the parameters --rg-library "L" --rg-platform "ILLUMINA" --rg-platform-unit "X" --rg-id "run#many" --no-novel-juncs --library-type fr-firststrand -p 12. The resulted Bam files were converted to tagDirectory using HOMER and BigWig were produced using the makeUCSCfile HOMER command.
RNA reads quantification was performed using HOMER analyzeRepeats.pl commands with the parameters: rna mm10 -count exons -condenseGenes -noadj -strand -.
Differential expression analysis was performed using HOMER getDiffExpression.pl command with the default parameters which performs differential expression with Deseq2.
Single Cell ATAC-seq Analysis
Sequencing reads were aligned using Cellranger-atac version1.1.0 (from 10xGenomics®) and the resulted sorted bam files were structured into hdf5 snapfiles (Single-Nucleus Accessibility Profiles) using snaptools version 1.4.1. Quality control analysis was performed using SnapATAC 1.0.0.
(ref 35 ). Cells with logUMI in [3.5-5] and fragment overlapping peaks above 25% were selected. They were cleaned by eliminating bins overlapping with ENCODE Blacklist regions 36 generated to visualize the data 39 . Fragments originating from the cells belonging to them same clusters were pooled using snaptools 1.4.1 and peak calling was performed using MACS2 version 2.1.2 for each of the clusters 40 .
Protein Extraction and Western-blot Analysis
Nuclear extracts were performed using pooled forelimb and hindlimb buds at E11.5 from wild type and Hoxa11-/-embryos. Western blot was performed using the anti-HOXA11 antibody (1:500) (SAB1304728, Sigma) and the anti-H3 antibody (1:3000) (abcam) was used as loading control.
